newsfilter
← Latest News
PR Newswire·

Braxia Scientific to Discuss Psychiatric Treatment Discovery and Development with Oxford University Researchers at AIMday Experimental Medicine in Psychiatry on July 7, 2021

TORONTO, July 7, 2021 /PRNewswire/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE:BRAX) (OTC:BRAXF) (FWB: 496), a medical research and development company along with clinics providing innovative ketamine treatments for persons with depress